Immune Checkpoint Inhibitors Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

Table of Content

1 Industrial Chain Overview

• 1.1 Immune Checkpoint Inhibitors Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Immune Checkpoint Inhibitors
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Type
  • 1.3.1 PD-1/PD-L1
  • 1.3.2 CTLA-4
• 1.4 End-Use List
  • 1.4.1 Demand in Lung Cancer
  • 1.4.2 Demand in Colorectal Cancer
  • 1.4.3 Demand in Breast Cancer
  • 1.4.4 Demand in Prostate Cancer
  • 1.4.5 Demand in Melanoma
  • 1.4.6 Demand in Blood Cancer
  • 1.4.7 Demand in Others
• 1.5 Global Market Overview
  • 1.5.1 Global Market Size and Forecast, 2015-2025
  • 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 Bristol Myer Squibb Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 AstraZeneca Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Merck & Co. Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 Roche / Genentech Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 Incyte Corporation Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 NewLink Genetics Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 ArGEN-X Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Seattle Genetics Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 Pfizer Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 MacroGenics Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning
    • 3.2.11 Celldex Therapeutics Overview
      • 3.2.11.1 Product Specifications
      • 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.11.3 Recent Developments
      • 3.2.11.4 Future Strategic Planning
    • 3.2.12 CureTech Overview
      • 3.2.12.1 Product Specifications
      • 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.12.3 Recent Developments
      • 3.2.12.4 Future Strategic Planning
    • 3.2.13 Immutep Overview
      • 3.2.13.1 Product Specifications
      • 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.13.3 Recent Developments
      • 3.2.13.4 Future Strategic Planning
    • 3.2.14 Innate Pharma Overview
      • 3.2.14.1 Product Specifications
      • 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.14.3 Recent Developments
      • 3.2.14.4 Future Strategic Planning
    • 3.2.15 Sorrento Therapeutics Overview
      • 3.2.15.1 Product Specifications
      • 3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.15.3 Recent Developments
      • 3.2.15.4 Future Strategic Planning
    • 3.2.16 GlaxoSmithKline Overview
      • 3.2.16.1 Product Specifications
      • 3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.16.3 Recent Developments
      • 3.2.16.4 Future Strategic Planning
    • 3.2.17 GITR, Inc Overview
      • 3.2.17.1 Product Specifications
      • 3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.17.3 Recent Developments
      • 3.2.17.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Product Type
      • 5.2.1 Market in PD-1/PD-L1
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in CTLA-4
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Lung Cancer
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in Colorectal Cancer
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development
        • 6.2.3 Market in Breast Cancer
          • 6.2.3.1 Market Size
          • 6.2.3.2 Situation & Development
        • 6.2.4 Market in Prostate Cancer
          • 6.2.4.1 Market Size
          • 6.2.4.2 Situation & Development
        • 6.2.5 Market in Melanoma
          • 6.2.5.1 Market Size
          • 6.2.5.2 Situation & Development
        • 6.2.6 Market in Blood Cancer
          • 6.2.6.1 Market Size
          • 6.2.6.2 Situation & Development
        • 6.2.7 Market in Others
          • 6.2.7.1 Market Size
          • 6.2.7.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast
          • 7.2.2 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table Bristol Myer Squibb Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Bristol Myer Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table AstraZeneca Overview List

        Table Immune Checkpoint Inhibitors Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Merck & Co. Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Merck & Co. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Roche / Genentech Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Roche / Genentech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Incyte Corporation Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Incyte Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table NewLink Genetics Overview List

        Table Immune Checkpoint Inhibitors Business Operation of NewLink Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table ArGEN-X Overview List

        Table Immune Checkpoint Inhibitors Business Operation of ArGEN-X (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Seattle Genetics Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Seattle Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Pfizer Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table MacroGenics Overview List

        Table Immune Checkpoint Inhibitors Business Operation of MacroGenics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Celldex Therapeutics Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Celldex Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table CureTech Overview List

        Table Immune Checkpoint Inhibitors Business Operation of CureTech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Immutep Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Immutep (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Innate Pharma Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Innate Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sorrento Therapeutics Overview List

        Table Immune Checkpoint Inhibitors Business Operation of Sorrento Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table GlaxoSmithKline Overview List

        Table Immune Checkpoint Inhibitors Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table GITR, Inc Overview List

        Table Immune Checkpoint Inhibitors Business Operation of GITR, Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Product Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Immune Checkpoint Inhibitors Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in PD-1/PD-L1, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in PD-1/PD-L1, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in CTLA-4, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in CTLA-4, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Lung Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Lung Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Breast Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Breast Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Prostate Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Prostate Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Melanoma, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Melanoma, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Blood Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Blood Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume